News

As part of the agreement, Astimex is expected to cover distribution of Asonor in Sweden and Finland by the mid of year 2010. Asonor has its presence in

The new facility will deliver an additional 300 million treatments of albendazole per year. The global programme to eliminate LF began in 2000, under which more than 1.9

Epigenetic mechanisms play a major role during an excessive inflammatory response by controlling immune cell differentiation and inflammatory gene expression. Under the agreement, GSK will be able to

The patent technology covers future iterations of the company’s SecondLook Digital Computer-Aided Detection (CAD) solution with potential application to the company’s other image analysis solutions. Ken Ferry, President

The proton therapy systems have been shown to tailor high-energy doses to attack cancerous tumors while minimizing damage to adjacent tissue, whereas conventional cancer treatment using high-energy x-rays

Under the agreement, LEO Pharma’s clinical expertise and Intomics technology in analyzing biological data will be combined to help the LEO Pharma quickly develop better and safer drugs.

Headquartered in Norcross, GA, Spear has been instrumental in helping the client develop and implement comprehensive project controls programs including methods, procedures, processes and systems. Currently, Spear is

Limerick BioPharma said that LIM-0705 is a small-molecule compound being developed to administer alongside tacrolimus, a calcineurin inhibitor widely used to block the body from rejecting transplanted organs.

LCT Biomedical was formed in 2009 to facilitate the commercial development of Diabecell in Russia. Diabecell is designed to normalise the lives of people with insulin dependent diabetes.